Diana Roettger, PhD, and Olga Kubassova, PhD[email protected]MRIAdvanced imaging offers insight into targeted therapiesMajor breakthroughs are emerging in the development of targeted therapies that use the body's own immune system to attack cancer cells. But traditional methods of measuring the success of drug candidates are slow and expensive. Could advanced imaging help? Diana Roettger, PhD, and Olga Kubassova, PhD, of the Image Analysis Group offer a perspective.February 5, 2019Page 1 of 1Top StoriesMRIMRI, PET reveal distinct brain changes in loneliness and social isolationPrior studies frequently have used the terms interchangeably and applied measures designed for one construct when investigating the other.MRIPodcast: Hospital accreditation isn’t a safety net for MRIAISIIM-CAIMI program chairs talk medical imaging AI's evolutionCTLDCT predicts vertebral fracture risk in heavy smokersSponsor ContentFREE webinar: find your imaging capacity